The scientific advisors and founders of Alnylam Pharmaceuticals are among the world's leaders in RNA interference and in medical research. The Alnylam Scientific Advisory Board and advisors include:

Phillip Sharp, Ph.D., 1993 Nobel Prize winner in Physiology or Medicine for the discovery of "split genes," National Academy of Sciences member, cofounder of Biogen (now Biogen Idec), and a cofounder and member of the Board of Directors of Alnylam

David Bartel, Ph.D., Member of the Whitehead Institute and Associate Professor of Biology at MIT, noted RNA and RNAi expert, and a cofounder of Alnylam

Fritz Eckstein, Ph.D., inventor of phosphorothioate modifications and professor of Chemistry, at the Max Planck Institute for Experimental Medicine, Göttingen

Edward Harlow, Ph.D., Chair of the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School, and member of the National Academy of Sciences

Robert Langer, Ph.D., Germeshausen Professor at MIT and the only active member of all three U.S. National Academies - the National Academy of Sciences, the Institute of Medicine, and the National Academy of Engineering

Judy Lieberman, M.D., Ph.D., Senior Investigator at the CBR Institute for Biomedical Research, and Professor of Pediatrics, at Harvard Medical School, and the Director of the Division of AIDS at Harvard Medical School

Stephen N. Oesterle, M.D., Senior Vice President for Medicine and Technology, Medtronic, Inc.

Paul Schimmel, Ph.D., HHahn Professor of Molecular Biology and Chemistry at Scripps Research Institute, National Academy of Sciences, American Academy of Arts and Sciences, and Institute of Medicine member, cofounder of Cubist, Alkermes and Repligen, and a cofounder and member of the Board of Directors of Alnylam

Edward Scolnick, M.D, Director of the Psychiatry Initiative at the Broad Institute; former President of Merck Research Laboratories; National Cancer Institute; National Heart Institute

Markus Stoffel, M.D., Ph.D., Professor for Metabolic Diseases at the Institute of Molecular Systems Biology, Swiss Federal Institute of Technology (ETH) in Zurich

Thomas Tuschl, Ph.D., Associate Professor at Rockefeller University, discoverer of the structure of mammalian RNAi, and a cofounder of Alnylam

Phillip D. Zamore, Ph.D., Gretchen Stone Cook Professor of Biomedical Sciences at the University of Massachusetts Medical School, one of the discoverers of RNAi and co-founder of Alnylam